Coverage
-
February 28, 2014
Actelion Pharmaceuticals Ltd. reached a settlement with generic-drug makers in its quest for a New Jersey federal court to confirm antitrust laws don't require the company to supply its patented blood pressure drug Tracleer for generics development, according to an order dismissing the case Friday.
4 other articles on this case.
View all »